Kandasamy S B, Williams B A
Neuropharmacology. 1983 May;22(5):621-8. doi: 10.1016/0028-3908(83)90154-5.
Intracerebroventricular administration of prototype non-peptide opioid receptor (mu, kappa, sigma) agonists, morphine, ketocyclazocine and N-allyl normetazocine (SKF 10,047) and an agonist at both kappa and sigma receptors, pentazocine, induced hyperthermia in guinea-pigs. Similar administration of peptide opioids like beta-endorphin (BE), methionine enkephalin (Met-E), leucine enkephalin (Leu-E) and their synthetic analogues D-ala2-methionine-enkephalinamide (D-ala2-Met-E) and D-ala2-leucine-enkephalinamide (D-ala2-Leu-E) also caused hyperthermia. Of the three anion transport systems (iodide, hippurate and liver-like) present in the choroid plexus, only the liver-like transport system seems to be important to central inactivation of beta-endorphin, D-ala2-Met-enkephalin and D-ala2-Leu-enkephalin since iodipamide (an inhibitor of the liver-like transport system) augmented the hyperthermia. Prostaglandins (PG) and norepinephrine (NE) were not involved in peptide- and non-peptide opioid-induced hyperthermia because a prostaglandin synthesis inhibitor, indomethacin, and an alpha-adrenergic receptor blocker, phenoxybenzamine, had no thermolytic effect. Likewise cAMP was not required since a phosphodiesterase inhibitor, theophylline, did not accentuate the hyperthermia due to administration of peptide and non-peptide opioids. Naloxone-sensitive receptors were involved in the induction of hyperthermia by morphine and beta-endorphin since naloxone attenuated the effect. In contrast, the hyperthermic responses to ketocyclazocine, SKF 10,047, pentazocine, Met-enkephalin, Leu-enkephalin, D-ala2-Met-enkephalin and D-ala2-Leu-enkephalin were not antagonized by naloxone. Lack of antagonism of naloxone on pyrogen, arachidonic acid, PGE2, dibutyryl cAMP and NE-induced hyperthermia indicates that endogenous opioid peptides are not likely to be central mediators of the hyperthermia induced by these agents.
向豚鼠脑室内注射原型非肽类阿片受体(μ、κ、σ)激动剂吗啡、酮环唑新和N-烯丙基去甲左啡诺(SKF 10,047)以及κ和σ受体的双激动剂喷他佐辛,可诱导体温升高。类似地,注射β-内啡肽(BE)、甲硫氨酸脑啡肽(Met-E)、亮氨酸脑啡肽(Leu-E)等肽类阿片及其合成类似物D-丙氨酸2-甲硫氨酸脑啡肽酰胺(D-丙氨酸2-Met-E)和D-丙氨酸2-亮氨酸脑啡肽酰胺(D-丙氨酸2-Leu-E)也会引起体温升高。脉络丛中存在的三种阴离子转运系统(碘化物、马尿酸盐和类肝转运系统)中,似乎只有类肝转运系统对β-内啡肽、D-丙氨酸2-甲硫氨酸脑啡肽和D-丙氨酸2-亮氨酸脑啡肽的中枢失活很重要,因为碘帕醇(类肝转运系统的抑制剂)会加剧体温升高。前列腺素(PG)和去甲肾上腺素(NE)不参与肽类和非肽类阿片诱导的体温升高,因为前列腺素合成抑制剂吲哚美辛和α-肾上腺素能受体阻滞剂酚苄明没有解热作用。同样,环磷酸腺苷(cAMP)也不是必需的,因为磷酸二酯酶抑制剂茶碱不会因注射肽类和非肽类阿片而加剧体温升高。纳洛酮敏感受体参与了吗啡和β-内啡肽诱导的体温升高,因为纳洛酮可减弱这种作用。相反,纳洛酮不能拮抗酮环唑新、SKF 10,047、喷他佐辛、甲硫氨酸脑啡肽、亮氨酸脑啡肽、D-丙氨酸2-甲硫氨酸脑啡肽和D-丙氨酸2-亮氨酸脑啡肽引起的体温升高反应。纳洛酮对热原、花生四烯酸、前列腺素E2、二丁酰环磷酸腺苷和去甲肾上腺素诱导的体温升高缺乏拮抗作用,表明内源性阿片肽不太可能是这些药物诱导体温升高的中枢介质。